regeneron

Regeneron Pharma beats Q3 earnings

Regeneron Pharma beats Q3 earnings

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its third quarter earnings for fiscal year 2017 and beat analysts’ estimates, sending shares up almost 7 percent shortly after open on Wednesday.For the third quarter, Regeneron reported r..